Human Genome Sciences, Inc.
Industry
- Pharmaceuticals
- Biotechnology
- Large Molecule
- Antibodies
- Drug Discovery Technologies
- Genomics-Proteomics
- Large Molecule
Latest on Human Genome Sciences, Inc.
Investors’ Short Memories The events that followed 11 September 2001 brought to companies like Human Genome Sciences, Inc. and Acambis PLC (subsequently acquired by GSK plc and Sanofi , re
The upcoming advisory committee reviews of the first coronavirus vaccine(s) and Biogen, Inc. ’s aducanumab for Alzheimer’s should be two historic panel meetings, prompting a look back at
As the completely abnormal starts to feel routine, the Pink Sheet offers periodic dispatches about how the coronavirus pandemic is changing the operations of sponsors and regulators. Here are some r
A generics trade association believes the US can boost its drug manufacturing base if the government is willing to pay a premium for the essential medicines the new facilities would produce. Pricing o